Mutations in chromatin machinery and pediatric high-grade glioma-Reference-Cited by-同舟云学术

Mutations in chromatin machinery and pediatric high-grade glioma

Published:2016-03-04 Issue:3 Volume:2 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Lulla Rishi R.¹,Saratsis Amanda Muhs²^ORCID,Hashizume Rintaro²³

Affiliation:

1. Department of Pediatrics—Hematology, Oncology, Neuro-Oncology and Stem Cell Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

2. Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

3. Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Abstract

Mutations in chromatin machinery define pediatric high-grade gliomas; efforts to define and target their functions are under way.

Funder

The Matthew Larson Foundation for Pediatric Brain Tumors

Rally Foundation

Bear Necessities Pediatric Cancer Foundation

National Institutes of Health

John McNicholas Pediatric Brain Tumor Foundation

The Bagan Afmily Fellowship at the Neurosurgery Research and Education Foundation

The Cure Starts Now Foundation

Northwestern Memorial Faculty Founation

Northwestern University Clinical and Translational Sciences Institute Award

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference72 articles.

1. Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

2. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

3. Advances toward an understanding of brainstem gliomas;Donaldson S. S.;J. Clin. Oncol.,2006

4. Diffuse intrinsic pontine glioma: poised for progress

5. Diffuse intrinsic pontine glioma: A reassessment;Robison N. J.;J. Neurooncol.,2014

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies;Cancer Letters;2024-05

2. Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma;Cancer & Metabolism;2024-04-09

3. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort;Neuro-Oncology;2024-02-22

4. New progress in the treatment of diffuse midline glioma with H3K27M alteration;Heliyon;2024-01

5. Immunohistochemistry Detection of Histone H3 K27M Mutation in Human Glioma Tissue;Applied Immunohistochemistry & Molecular Morphology;2023-12-11